TwitterLinkedInFacebookInstagram

 | 

FacebookSearch
United States
SureQuick HBV

DETECTION OF HEPATITIS B SURFACE ANTIGEN

The test is suitable for laboratory testing and screening using venipuncture whole blood, serum, or plasma specimens. CE marked as an in vitro diagnostic device.

Key Product Features:

Easy-to-Use
• Simple procedure format1. Drop specimen sample
2. Add buffer
3. Wait for result
• Rapid results within 15 minutes
• Rapid detection of HBsAg in venipuncture whole blood, serum, or plasma.
• Ambient storage and transport conditions: 2°C - 30°C (36°F - 86°F).

Accurate & Reliable
• Over 99.86% accurate:◦ Sensitivity: 99.87%
◦ Specificity: 99.86%
• Includes a control line to confirm the validity of the test.
• Shelf life of 24 months from the date of manufacture
• Utilizing monoclonal and polyclonal antibodies to detect elevated levels of HBsAg in whole blood, serum, or plasma.

Accessible
• Competitively priced for large-scale programs.
• Short lead times

Downloadable Information

Prevalence & Trends

Various clinical stages, including latent, asymptomatic infection, are common in Hepatitis B (HBV). HBV is a preventable and curable viral infection primarily transmitted through blood contact. If left untreated, it can result in serious health complications, notably liver disease.

  • Hepatitis B affects approximately 296 million people, including over 6 million children under the age of 5.(1)
  • Hepatitis B contributes to an estimated 820,000 deaths every year.(1)
  • Most people with chronic HBV infection are asymptomatic.(2)
  • In 2016, the WHO adopted a strategy to reduce new viral Hepatitis infections by 90% and reduce deaths by 65% by 2030.(3)
  1. CDC 2022, Hepatitis B Fast Facts https://www.cdc.gov/globalhealth/immunization/diseases/hepatitis-b/data/fast-facts.html
  2. CDC 2022, Hepatitis B FAQs for the Public https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#:~:text=Most%20people%20with%20chronic%20HBV,i.e.%2C%20primary%20liver%20cancer
  3. WHO 2016, WHO encourages countries to act now to reduce deaths from viral hepatitis https://www.who.int/news/item/20-07-2016-who-encourages-countries-to-act-now-to-reduce-deaths-from-viral-hepatitis

Flexible Specimens for Clinical and Non-Clinical Settings

Step 1 -
Collect Specimen & transfer to the specimen area of the casette
Step 2 -
Add 1 drop of buffer and set timer
Step 3 -
Read between 15 and 30 minutes
Negative
Line in the C Zone

Positive
Line in the C & T Zones

Invalid Result
1. Line only in the T zone, or
2. Neither line shows

Training

Training materials for our products are available and recommended to ensure proper utilization by healthcare professionals. These materials cover specimen handling, storage, and equipment maintenance, ensuring accurate results. Request more product information »

Product not available in all territories. Please contact us for details. Please read full instructions before use.

© OraSure Technologies Inc., 2024